Orexo
ORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000736415 (+2 more)
- LEI:
- 549300LJ5CCWDPTK9Z08
- Country:
- Sweden
- Address:
- Box 303, 751 05 UPPSALA
- Website:
- https://orexo.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of mental illness and substance use disorders. The products are commercialized by Orexo in the US or via partners worldwide. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercializes its lead product ZUBSOLV® for the treatment of opioid use disorder. - Developed four commercial pharmaceutical products with worldwide approval - Addresses unmet need within the growing space of mental illness and addiction disorders - Broad product portfolio and development pipeline of traditional pharma products and digital therapies - Strategic focus on portfolio expansion through development, licensing and M&A - Strong cash generation from the business area US Pharma enabling to invest in future growth
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-08 17:15 |
Regulatory News Service
Report from Orexo AB’s annual general meeting 8 May 2025
|
English | 175.7 KB | |
| 2025-05-08 17:15 |
Regulatory News Service
Kommuniké från Orexo AB:s årsstämma den 8 maj 2025
|
Swedish | 148.7 KB | |
| 2025-05-06 08:00 |
Quarterly Report
|
Swedish | 4.6 MB | |
| 2025-05-06 08:00 |
Quarterly Report
|
English | 4.6 MB | |
| 2025-02-06 08:00 |
Annual Report
|
Swedish | 5.3 MB | |
| 2025-02-06 08:00 |
Annual Report
|
English | 5.3 MB | |
| 2024-12-18 11:45 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från Orexo AB:s extra bolagsstämma den 18 december 2024
|
Swedish | 124.4 KB | |
| 2024-12-18 11:45 |
Declaration of Voting Results & Voting Rights Announcements
Report from Orexo AB’s extraordinary general meeting, December 18 2024
|
English | 127.1 KB | |
| 2024-12-15 21:00 |
Regulatory News Service
Orexo har löst patenttvisten mot Sun Pharmaceutical Industries för Zubsolv i USA
|
Swedish | 130.1 KB | |
| 2024-12-15 21:00 |
Legal Proceedings Report
Orexo resolves Zubsolv US patent litigation with Sun Pharmaceutical Industries
|
English | 135.7 KB | |
| 2024-12-02 08:00 |
Regulatory News Service
Orexo och GAIA överens om att avsluta partnerskapsavtalet för Deprexis®
|
Swedish | 179.7 KB | |
| 2024-12-02 08:00 |
Regulatory News Service
Orexo and GAIA agree to terminate the partnership for Deprexis®
|
English | 179.1 KB | |
| 2024-11-21 18:00 |
Proxy Solicitation & Information Statements
Notice of Extraordinary General Meeting in Orexo AB (publ)
|
English | 188.2 KB | |
| 2024-11-21 18:00 |
Regulatory News Service
Kallelse till extra bolagsstämma i Orexo AB (publ)
|
Swedish | 44.5 KB | |
| 2024-10-24 08:00 |
Quarterly Report
|
Swedish | 4.0 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-11 | Nikolaj Arrild Sørensen | Other | Buy | 2,460 | 35,178.00 SEK |
| 2025-04-04 | Nikolaj Arrild Sørensen | Other | Buy | 3,500 | 47,530.00 SEK |
| 2024-03-26 | Fredrik Järrsten | Other | Buy | 3,000 | 44,040.00 SEK |
| 2023-11-24 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 44,640.00 SEK |
| 2023-11-08 | Fredrik Järrsten | Other | Buy | 1,500 | 23,715.00 SEK |
| 2023-02-24 | Nikolaj Arrild Sørensen | Other | Buy | 11,500 | 188,945.00 SEK |
| 2023-01-27 | Fredrik Järrsten | Other | Buy | 4,500 | 79,695.00 SEK |
| 2022-07-26 | Michael Matly | Other | Buy | 2,820 | 60,777.77 SEK |
| 2022-07-21 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 61,500.00 SEK |
| 2022-07-15 | James Noble | Other | Buy | 18,500 | 394,252.80 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP |